These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3016900)

  • 21. Phosphodiesterase and its Ca2+-dependent activating factor in bovine thyroid.
    Yagura T; Azuma Y; Akazawa Y; Nagata I; Uchino H
    Endocrinology; 1978 Nov; 103(5):1534-40. PubMed ID: 218780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of immunosuppression by cyclosporins.
    Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides].
    Tkachuk VA; Men'shikov MIu
    Biokhimiia; 1981 Jun; 46(6):963-73. PubMed ID: 6266519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin.
    Epstein PM; Fiss K; Hachisu R; Andrenyak DM
    Biochem Biophys Res Commun; 1982 Apr; 105(3):1142-9. PubMed ID: 6284165
    [No Abstract]   [Full Text] [Related]  

  • 25. Isomerase modification.
    Rakitzis ET
    Nature; 1989 Aug; 340(6232):351-2. PubMed ID: 2666859
    [No Abstract]   [Full Text] [Related]  

  • 26. On the mechanism of activation of cyclic mucleotide phosphodiesterase by calmodulin.
    Wang JH; Sharma RK; Huang CY; Chau V; Chock PB
    Ann N Y Acad Sci; 1980; 356():190-204. PubMed ID: 6263147
    [No Abstract]   [Full Text] [Related]  

  • 27. Structure-based design of a cyclophilin-calcineurin bridging ligand.
    Alberg DG; Schreiber SL
    Science; 1993 Oct; 262(5131):248-50. PubMed ID: 8211144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
    Tkachuk VA; Lazarevich VG; Men'shikov MIu; Severin SE
    Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of experimental diabetes and insulin on cyclic AMP phosphodiesterase and its protein activator in rat adipose tissue.
    Solomon SS; Palazzolo M; McPherson J; Smoake A
    Diabetes; 1981 May; 30(5):372-6. PubMed ID: 6262167
    [No Abstract]   [Full Text] [Related]  

  • 30. 1H NMR studies on bovine cyclophilin: preliminary structural characterization of this specific cyclosporin A binding protein.
    Dalgarno DC; Harding MW; Lazarides A; Handschumacher RE; Armitage IM
    Biochemistry; 1986 Nov; 25(22):6778-84. PubMed ID: 3542017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution structure of the cyclosporin A/cyclophilin complex by NMR.
    Thériault Y; Logan TM; Meadows R; Yu L; Olejniczak ET; Holzman TF; Simmer RL; Fesik SW
    Nature; 1993 Jan; 361(6407):88-91. PubMed ID: 8421500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of lipids on the binding of calmodulin with cyclic nucleotide phosphodiesterase].
    Severin SE; Shvets VI; Tkachuk VA
    Biokhimiia; 1983 Aug; 48(8):1337-46. PubMed ID: 6313075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cyclophilin function in HIV-I infection by cyclosporin A.
    Huss R
    Immunol Today; 1996 Jun; 17(6):259-60. PubMed ID: 8962627
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy.
    Kallen J; Spitzfaden C; Zurini MG; Wider G; Widmer H; Wüthrich K; Walkinshaw MD
    Nature; 1991 Sep; 353(6341):276-9. PubMed ID: 1896075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Ca2+ and calmodulin on enzymes of cyclic nucleotide metabolism in ox neurohypophyseal secretosomes.
    Dartt Da; Torp-Pedersen C; Thorn NA
    Ann N Y Acad Sci; 1980; 356():369-70. PubMed ID: 6112949
    [No Abstract]   [Full Text] [Related]  

  • 36. [Allosteric regulation of Ca2+-calmodulin-dependent phosphodiesterase activity from the bovine brain].
    Bobruskin ID; Shaĭkhin SM; Muratova MV; Baranova LA; Severin ES
    Biokhimiia; 1987 Aug; 52(8):1344-52. PubMed ID: 2822149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of pharmacological preparations for the study of calmodulin interaction with enzymes].
    Feoktistov IA; Baldenkov GN; Men'shikov MIu; Larionov NP
    Vopr Med Khim; 1987; 33(2):27-31. PubMed ID: 3037792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophilins and immunosuppression by cyclosporins and macrolide structures.
    Schreier MH
    Acta Derm Venereol Suppl (Stockh); 1994; 186():100. PubMed ID: 7521103
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue levels of calmodulin in experimental diabetes.
    Perez de Gracia B; Ahluwalia G; Rhoads AR; West WL
    Ann N Y Acad Sci; 1980; 356():422. PubMed ID: 6112956
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
    Crimaldi AA; Kuo IC; Coffee CJ
    Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.